Clinical trial
Evaluate the Safety and Efficacy of a 5-HT4 Agonist in Chronic Constipation…
NCT00391820 · Alfasigma S.p.A., Industry · Completed
Key facts
| NCT number | NCT00391820 |
|---|---|
| Title | Evaluate the Safety and Efficacy of a 5-HT4 Agonist in Chronic Constipation (ACCORD Trial) |
| Official title | A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of TD-5108 for the Treatment of Chronic Constipation |
| Lead sponsor | Alfasigma S.p.A., Industry |
| Collaborators | Theravance Biopharma Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Constipation |
| Intervention type | Drug |
| Interventions | TD-5108 |
| Enrollment | 360 |
| Start date | Oct 1, 2006 |
| Completion | May 1, 2007 |
| First posted | Oct 24, 2006 |
| Last update posted | Jul 8, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: